Meconium staining of the amniotic fluid and the meconium aspiration syndrome (MAS will likely remain common occurrences faced by health care providers. Unfortunately, our understanding of these entities is incomplete. There are a number of issues which 
Introduction
Meconium stained amniotic fluid is a common finding in labour, particularly in the term and post-term pregnancy, the mechanism for its occurrence is still complex and unknown, but there are many theories attributed to its pathophysiology [1, 2] . The most MAS continues to be a threat to many newborns throughout the world, with a case fatality rate of 5% (as much as 40%), in addition to short-and long-term pulmonary and neurodevelopmental sequelae [3] . Pathophysiology of meconium aspiration syndrome (MAS) is complex and interactions between individual pathomechanisms are still not completely understood [4] . As recently shown, inflammation plays a significant role in the pathogenesis of MAS. Activated cells release and stimulate production of a wide variety of mediators, including cytokines, enzymes, reactive species, and other biologically active substances in meconium-injured lungs. However, there are many other drugs, e.g. anti-cytokine antibodies, inhibitors of complement, inhibitors of angiotensin converting enzyme, anticoagulants, inhibitors of proteolytic enzymes, calcium-channel blockers etc. that may be beneficial in MAS [5] .
Visfatin is (52KDa) a cytokine that has been identified as a growth factor for early B cell, termed pre-B cell colony enhancing factor, It is expressed in visceral fat intuitively expressed in myometrium, placenta, all layer of human fetal membrane [6] and it is anti-apoptotic for both amniotic epithelial and mesenchymal cell and neutrophils [7] .
Collectively these finding suggest that vifatin play role in inflammatory process in regulation of other pro inflammatory cytokines and in the preservation of immune cell [8] . In this paper we want to study the association between visfatin and MSAF.
Method and material
A case control study of 90 cases of a women presented in labor who meconium had 
Inclusion criteria
All pregnant women in labour with cephalic presentation, singleton pregnancy, with clear or meconium stained liquor irrespective of age, parity and stage of labour.
Artificial rupture of membranes or spontaneous rupture of membranes, those with previous normal deliveries or previous lower section caesarean section.
Exclusion criteria
The presence of any sort of infection, mal-presentation, multiple pregnancies, pre maternal medical diseases, fetal malformation, intrauterine fetal demise and post-term pregnancy.
Biochemical Investigation
Blood samples was collected from participating women for complete blood picture, blood sugar, renal and liver function test and serum for visfatin level.
Statistics
Statistical analysis was done by using SPSS (statistical package for social sciences version 20). In which we use independent sample T-test for measurement data and chi square (X2) test for categorical data. P-value <0.05 as significant.
Results
The result of our study which consist of 45 with meconium stained amniotic fluid and 45 clear amniotic fluid. The median of number of para for both groups was one. The comparison of certain parameters between the two groups were shown in (Table 1) . 
Discussion
Meconium-stained amniotic fluid is commonly found in obstetrics: it occurs in 9-20% of deliveries. Meconium passage into the amniotic fluid may be an antepartum or intrapartum event [9] . Meconium aspiration syndrome (MAS) remains one of the most common causes of neonatal respiratory distress and there were a number of unresolved controversies concerning these issues [10] . In our study the MSAF women age between 20-30 years constitute 82.3%, The primigravidas constitute 60% of them, their gestational age of 39-42 weeks constitute 66, 67%, and the percentage of caesarean delivery was 68.9% which is higher than that of vaginal delivery. Oyelese et al [11] concluded that the rising incidence of meconium-stained amniotic fluid with gestational age is consistent with the hypothesis that fetal maturation is a major etiologic factor in meconium passage. Sedaghatian et al [12] , this study showed that the risk of MSAF increased with higher GA, Alexander GR [13] was found an increased risk of MSAF for advancing gestational age, indicators of fetal stress. P Swain et al [14] and Basima Sh. [2] reports that MSAF are associated with higher incidence of LSCS & higher gestational weeks.
In this study we found that the level of visfatin is increased significantly in MSAF in comparison with the CAF group, we found no similar study, which needs further studies on a large number of women, but Rao et al [15] found that The incidence of MSAF was significantly higher in the group with acute chorioamnionitis/funisitis and
